MedPath
NMPA Approval

Gemcitabine Hydrochloride for Injection

国药准字H20233706

June 14, 2023

Drug Information

注射用盐酸吉西他滨

注射剂

1.0g(按C₉H₁₁F₂N₃O₄计)

化学药品

June 14, 2023

Company Information

Applicant Company

北京市海淀区阜石路69号碧桐园1号楼4层

Manufacturing Company

北京市昌平区科技园区利祥路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸吉西他滨 - NMPA 批准文号 | MedPath